Herantis Pharma Strengthens Management Team with New CMO
Herantis Pharma PlcCompany release 22 Jan 2021 at 9:00 am EET Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, today announced the full-time appointment of Magnus Sjögren, MD, PhD as Chief Medical Officer. Dr. Sjögren will assume the role of Chief Medical Officer effective as of 1[st] of May 2021. “We are delighted to add Magnus Sjögren to our management team. He brings an impressive skill set strongly complementary to our focus therapeutic areas at Herantis and a